Arrow Dx is excited to welcome our Winter-Spring 2025 cohort of young scientists from University of California, Berkeley: Arvind Swamynathan, Yashna Hasija, and Logan Krause! Their passion and expertise will drive innovation in diagnostic technology.
Arrow Dx
生物技术
Boston，Massachusetts 238 位关注者
Arrow Dx is creating precision diagnostics by combining AI and nanotechnology through a versatile, portable technology.
关于我们
Arrow Dx is combining Nanotechnology and Artificial Intelligence (AI) to create an inexpensive, sensitive test to screen early for non-alcoholic fatty liver disease (NAFLD). Our aim is to provide physicians with an alternative to liver biopsy which detects the disease too late. We are working to solve the lack of rapid, reliable, point-of-care, and inexpensive diagnostic devices by bring faster, inexpensive and mobile testing for many other applications that require a rapid response (e.g., epidemic/pandemics, public health crisis, early diagnosis for rising complex non-communicable diseases, testing in emergency rooms). Our technology makes it more affordable for smaller healthcare providers such as Physician Office Labs (~100,000 in the U.S.), independent physicians and public health workers to access diagnostics due to our significantly lower cost as well as our portable, small compact size. Finally, we are also working to create a test for COVID-19 as well as other viruses, initially quantifying the virus in wastewater to help public health authorities and later to detect it in biological samples from individuals and patients.
- 网站
-
https://www.arrowdx.com
Arrow Dx的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 领域
- NAFLD、NASH、Viruses、Bacteria、Material Science和Physical Chemistry
地点
-
主要
获取路线
US，Massachusetts，Boston，02115
Arrow Dx员工
动态
-
Insights that matter!?? The Fatty Liver Foundation's annual national survey is shaping the future of NAFLD and NASH care in the U.S. Understanding patient perspectives is key to advancing early detection and treatment options. Check out the findings to see how these insights can impact care standards. Read more here: https://bit.ly/3Xs6US2 #NAFLDDetection #MedicalTechnology #NAFLD
-
Liver disease often goes unnoticed until it’s too late - leading to expensive treatments, hospitalizations, and transplants. The numbers tell a clear story: ?? NAFLD-related healthcare costs exceed $100 billion annually in the US ?? A liver transplant can cost $800K+ per patient ?? Early detection could save millions in preventable costs At Arrow Dx, we’re developing AI-driven, ultra-sensitive biosensors to make early NAFLD detection affordable, fast, and accessible. The future of diagnostics is early, easy, and effective. Learn more: https://bit.ly/3NaYedg #HealthcareInnovation #EarlyDetection #NAFLDPrevention
-
-
Understanding the labels behind liver disease is crucial in advancing diagnosis and treatment. This review by the Children's Liver Disease Foundation explores the significance of terms like NAFLD, MASLD, NASH, and MASH. ?? Read more: https://bit.ly/4btIxt1 #NAFLD #NASH #MASH
-
Over 100 million adults worldwide are affected by NASH, a severe form of NAFLD. Early detection is key to better outcomes, and Arrow Dx is making it possible. Arrow Dx's proprietary technology enhances early disease detection, helping patients and physicians find effective treatments faster. Reliable, flexible, and fast - our diagnostics are shaping the future of healthcare. ?? Learn more: https://bit.ly/41wqorn #NAFLD #NASH #EarlyDetection #ArrowDx #HealthcareInnovation
-
Investors - the future of disease detection is here. Are you ready to be a part of it? Arrow Dx is transforming diagnostics with ultra-sensitive detection technology and AI-powered analysis, making early disease detection faster, more accurate, and accessible. From NAFLD to infectious diseases, our solutions are shaping the future of healthcare. ?? Learn more about our mission and investment opportunities here: https://lnkd.in/eyzmbvCW Join us as we redefine diagnostics and make a global impact!
-
?? Early detection saves lives! At Arrow Dx, we believe that identifying diseases like NAFLD/MAFLD, viral infections, and bacterial threats at their earliest stages can significantly improve outcomes. Our highly sensitive detection chips, powered by machine learning, bring accuracy and speed to diagnostics - helping doctors and patients make informed decisions faster. ?? Precision. Affordability. Accessibility. Learn more//arrowdx.com/
-
-
Did you know? Fatty liver disease is on the rise among young people, and the reason might surprise you. Understanding the risks early can make all the difference. Learn more about what’s driving this trend and how to protect your health. Read more here: https://bit.ly/41e2v7C
-
NAFLD affects 1 in 4 adults worldwide, yet the majority are unaware they even have it. Without intervention, NAFLD can quietly progress, increasing the risk of: - Liver Cirrhosis - Liver Cancer - Cardiovascular Disease (the leading cause of death in NAFLD patients) When detected early, lifestyle changes, medical interventions, and monitoring can significantly slow or even reverse disease progression. #NAFLD #Prevention
-
Recent research highlights that a diet rich in flavonoids, or bioactive compounds found in foods like apples, tea, and dark chocolate, may significantly reduce the risk of non-alcoholic fatty liver disease (NAFLD/MAFLD) among middle-aged adults. Incorporating these flavonoid-rich foods into your daily meals could be a proactive step toward better liver health. Learn more: https://bit.ly/3Cwgdcq